Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics. Alshehade SA. Clin Res Hepatol Gastroenterol 2024;48:102377.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alshehade SA. Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics. Clin Res Hepatol Gastroenterol 2024;48:102377.
PMID: 38772519